NCT05046756

Brief Summary

Recently, the use of mobile health is increasing for the purpose of managing prognosis such as recurrence, survival and quality of life by using a wearable smart band and a smartphone application. In the era of the 4th revolution, mobile health for the purpose of comprehensive prognosis for cancer patients is becoming a very good tool. It is possible to confirm the clinical significance of short-term and temporary health care through a mobile application and a smart band during the treatment process for cancer patients, but the study is insufficient to generalize the number of subjects. Therefore, for colon cancer patients who need prognosis management after surgery, we will investigate the effect of a mobile application using a smart band which has a modular structure reflecting the treatment method and treatment process after surgery. This study targets patients who underwent prostate cancer surgery. An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for prostate cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months. Control group is provided general education through the hospital brochure. Evaluation will be conducted 2-3days after surgery (before discharge), and at 1, 3, 6, and 12 months after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
324

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

2.1 years

First QC Date

September 7, 2021

Last Update Submit

September 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of body composition (weight, kg)

    According to time frame with between-group and within group, trends will be found.

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

Secondary Outcomes (10)

  • Change of Quality of life (EORTC-QLQ-C30)

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

  • Pain (Numeric rating scale, NRS)

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

  • Change of Quality of life (EORTC-QLQ-C29)

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

  • Physical activity (IPAQ-SF)

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

  • Grip strength

    Enrollment (postoperative 2-3days), postoperative 1month, 3month, 6month, 12month

  • +5 more secondary outcomes

Study Arms (2)

mHealth App and wearable device

EXPERIMENTAL

An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for colon cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months.

Device: mHealth App and wearable device

Education brochure

NO INTERVENTION

Control group is provided general education through the hospital brochure.

Interventions

An intervention group (App+IoT device) uses a smart care application for 12 months. This application was tailored for colon cancer patients and created by reflecting the treatment process after surgery. And they also uses a wearable smart band for 12 months.

mHealth App and wearable device

Eligibility Criteria

Age19 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who have been diagnosed with colorectal cancer and have undergone surgery (not related to chemotherapy treatment)
  • Patients aged 19 to 75 years old
  • Those who can use prognosis management applications and can perform regular follow-up inspections outpatients
  • Patients carrying Android or iOS smartphones
  • Patients who voluntarily decide to participate and give written consent after hearing detailed explanations about this study

You may not qualify if:

  • Those who are judged to be difficult to perform smartphone exercise and dietary management for colorectal cancer in general due to uncontrolled severe or underlying diseases, neuromuscular and musculoskeletal diseases
  • Serious complications of Clavein dindo classification grade 3 or higher after surgery
  • Patients who were not discharged within 2 weeks after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Korea University Anam Hospital

Seoul, Seongbuk-gu, 02841, South Korea

RECRUITING

Related Publications (1)

  • Kim I, Lim JY, Kim SW, Shin DW, Kim HC, Park YA, Lee YS, Kwak JM, Kang SH, Lee JY, Hwang JH. Effectiveness of personalized treatment stage-adjusted digital therapeutics in colorectal cancer: a randomized controlled trial. BMC Cancer. 2023 Apr 3;23(1):304. doi: 10.1186/s12885-023-10728-2.

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Wearable Electronic Devices

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and Supplies

Study Officials

  • Yoon-suk Lee

    Seoul St. Mary's Hospital

    PRINCIPAL INVESTIGATOR
  • Ji-Hye Hwang, Professor

    Seoul, Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seok-Ho Kang, Medical Doctor degree, College

CONTACT

Jeong-Myeon kwak

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2021

First Posted

September 16, 2021

Study Start

May 11, 2021

Primary Completion

May 30, 2023

Study Completion

May 30, 2024

Last Updated

September 16, 2021

Record last verified: 2021-09

Locations